Tamoxifen is primarily used for the treatment of hormone receptor-positive breast cancer in premenopausal and postmenopausal women. It is also employed in reducing the risk of breast cancer in high-risk populations. Additionally, tamoxifen can be used in the treatment of ductal carcinoma in situ (DCIS) after surgery and radiation therapy.
